(Reuters) – China’s National Medical Products Administration has approved domestic drugmaker Innovent Biologics’ weight control peptide injection’s entry into the market, the regulator said in a statement on Friday.
ADVERTISEMENT
A stock photo of a China's flag (Canva)
Previous Article
Comelec lifts suspension on Eric Yap’s proclamation as Benguet rep
Next Article
PH-US deal to fund technical aid for freight cargo railway project
Other News
Prosecution seeks Trillanes testimony on Duterte’s alleged unexpl ...
September 26, 2026
NCR minimum wage hike takes effect Sept. 26
September 26, 2026
Delos Santos wins Asian Games bronze, sets junior records
September 26, 2026
Sara Duterte denies ₱2-B cash from ex-cop
September 26, 2026
James Wan’s ‘Other Mommy’ haunts Philippine cinemas Oct. 7
September 25, 2026
